Prevalence of Kaposi sarcoma-associated herpesvirus (KSHV/HHV-8) varies greatly in different populations. We hypothesized that the actual prevalence of KSHV/HHV8
infection in humans is underestimated by the currently available serological tests. We analyzed four independent patient cohorts with post-surgical or post-
chemotherapy sepsis,
chronic lymphocytic leukemia and post-surgical patients with abdominal surgical interventions. Levels of specific KSHV-encoded
miRNAs were measured by reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and KSHV/HHV-8
IgG were measured by immunoassay. We also measured specific
miRNAs from Epstein Barr Virus (EBV), a virus closely related to KSHV/HHV-8, and determined the EBV serological status by ELISA for
Epstein-Barr nuclear antigen 1 (EBNA-1)
IgG. Finally, we identified the viral
miRNAs by in situ hybridization (ISH) in bone marrow cells. In training/validation settings using independent multi-institutional cohorts of 300 plasma samples, we identified in 78.50% of the samples detectable expression of at least one of the three tested KSHV-
miRNAs by RT-qPCR, while only 27.57% of samples were found to be seropositive for KSHV/HHV-8
IgG (P<0.001). The prevalence of KSHV
infection based on
miRNAs qPCR is significantly higher than the prevalence determined by seropositivity, and this is more obvious for immuno-depressed patients. Plasma viral
miRNAs quantification proved that
EBV infection is ubiquitous. Measurement of viral
miRNAs by qPCR has the potential to become the "gold" standard method to detect certain
viral infections in clinical practice.